Recently, IPO’d Coya has just reported cognition-improving and cognition-stabilizing results in an open label study in Alzheimer’s patients with Coya 301. In March 2023, Coya had reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback